Monthly reportPPB
Pharmacy and Poisons Board — April 2026
What this register recorded from PPB in April 2026, what other African authorities published in the same month that bears on it, and what we could not read in PPB’s own notices. Every figure here is a count of published regulatory actions. None of it is a finding about Pharmacy and Poisons Board.
What PPB published
| Reference | Date | Country | Product | Batches | Action | Class | Source |
|---|---|---|---|---|---|---|---|
| DEA-KE-2026-0007 | 30 Apr 2026 | KE | Cloxam Dry Syrup Sphinx Pharmaceuticals Limited, Kenya | 00082CXS | Recall | Unclassified | Tier 1 · Regulator-published |
What other authorities published
Against a manufacturer PPB has named
- GE healthcare Ireland — Egyptian Drug Authority (EG), 2026-04-01: Omnipaque 300 mg/ml
- WEST COAST PHARMACEUTICAL WORKS Ltd, India — Rwanda Food and Drugs Authority (RW), 2026-04-24: Akerol 2.5mg/5ml sp F/60ml
What we could not read in PPB’s notices
- 60 record(s) held from PPB in total
- 1 carry no publication date we could read
- 0 name neither a batch nor a stated reason
- 0 name no manufacturer
- 1 are searchable and API-available but carry noindex, because they are too incomplete for a public URL
- 0 have no archived copy of the original notice
Correcting this
Anything on this page that is wrong about Pharmacy and Poisons Board can be corrected by Pharmacy and Poisons Board, and a record published by one of its officers carries verification tier 0 — the rank only the issuing regulator can create. Nothing else on this register does.